Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation.
Tawnie J BraatenJulie R BrahmerPatrick M FordeDung LeEvan J LipsonJarushka NaidooMegan SchollenbergerLei ZhengClifton O BinghamAmi A ShahLaura C CappelliPublished in: Annals of the rheumatic diseases (2019)
ICI-induced IA can become a long-term disease necessitating management by rheumatology for immunomodulatory treatment. Importantly, the use of immunomodulatory treatment has not been shown to impact cancer outcomes in this study.